Jpmorgan Chase & CO Exscientia PLC Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Exscientia PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,042 shares of EXAI stock, worth $30,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,042
Previous 10,584
42.91%
Holding current value
$30,270
Previous $60,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EXAI
# of Institutions
89Shares Held
35MCall Options Held
22.8KPut Options Held
178K-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$28.5 Million0.15% of portfolio
-
Sb Global Advisers LTD London, X05.68MShares$28.5 Million3.51% of portfolio
-
Laurion Capital Management LP New York, NY5.14MShares$25.8 Million0.31% of portfolio
-
Baillie Gifford & CO3.85MShares$19.3 Million0.01% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C31.93MShares$9.68 Million0.4% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $614M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...